5-(3-吲哚基)亚甲基噻唑烷-2,4-二酮衍生物的合成及体外抗肿瘤活性探索

将N-取代吲哚-3-甲醛和2,4-噻唑烷二酮通过亚甲基键合,再对噻唑烷二酮氮取代,合成了一系列5-(3-吲哚基)亚甲基噻唑烷-2,4-二酮衍生物(e1-e9).采用IR,1H NMR和HRMS对其结构进行了表征;采用MTT法对目标物抑制5种癌细胞增殖活性进行了测试.结果表明,所有目标物对A549、HCT116和PC-9表现出抑制活性,其中吲哚氮被苄基取代的化合物e1和e3对测定的癌细胞增殖抑制活性与5-氟尿嘧啶(5-FU)相近,并且对A549和HCT116表现出中等的抑制活性(IC50<30μM)。     

在微波作用、无催化剂的条件下合成3-芳基亚甲基-1，3-二氢-2H-吲哚-2-酮类化合物

用DMF作溶剂，无催化剂、微波辐射的条件下，使吲哚-2-酮(1)和醛、酮(2)发 生缩合反应，合成了3-芳基亚甲基-1，3-二氢-2H-吲哚-2-酮类化合物，时间短、 收率高。     

利用磷试剂制备2-[4,5-二氢化-4-甲基-4-异丙基-5-氧代-1H-咪唑啉-2-基]-苯甲酸的衍生物

本文报告了利用磷试剂制备2-氧代-3-甲基-3-异丙基-3H-咪唑并[2,1-a]-1-氧代-异吲哚及其异构体3-氧代-2-甲基-2-异丙基-2H-咪唑并[2,1-a]-1-氧代-异吲哚和2-[4,5-二氢化-4-甲基-4-异丙基-5-氧代-1H-咪唑啉-2-基]-N,N-二烷基-苯甲酰胺的新方法。本文方法具有反应条件温和、反应时间较短和收率较高等特点。     

3,3-二甲基-2-(3-甲基薁乙烯基)-3H-吲哚衍生物的合成

1-甲酰基薁-3-甲酸甲酯和2,3,3-三甲基-3H-吲哚衍生物发生缩合反应,合成了一系列3,3-二甲基-2-(3-甲基薁乙烯基)-3H-吲哚衍生物,收率48%～64%,其结构经~1H NMR,IR和元素分析表征.     

无溶剂、无催化剂条件下5-[(3-吲哚基)-芳甲基]-2,2-二甲基-l,3-二氧六环-4,6-二酮的合成

在无溶剂和催化剂条件下，由芳香醛、吲哚、丙二酸亚异丙酯的三组分缩合反 应，制备了5．[(3-吲哚基)-芳甲基]-2，2-二甲基-1，3-二氧六环-4，6-二酮，产 率为70％～85％，产物结构经～1H NMR，IR确证．     

3-取代芳基-2-吲哚基膦酸酯的合成

本文根据Fischer吲哚合成法制备了一系列的3-取代芳基-2-吲哚基膦酸酯. 盐酸苯肼与o,o-二异丙基-4-氯-苯乙酰基膦酸酯在无水酒精中反应, O,O-二异丙基-(4'-氯苯-3H-吲哚-2-膦酸酯能被分离出来, 而且它的异构化最终产物能被观察到.     

在三乙基苄基氯化铵相转移催化下水相中(E)-3-亚苄基-2,3-二氢吲哚-2-酮衍生物的合成

以芳醛和2,3-二氢吲哚为原料, 以水为溶剂, 在室温以三乙基苄基氯化铵为催化剂合成了一系列的(E)-3-亚苄基-2,3-二氢吲哚-2-酮衍生物. 该方法具有反应条件温和、立体选择性好、产率高(72%～96%)和环境友好等优点. 产物的结构通过熔点, IR, ¹H NMR和元素分析表征.     

无溶剂、无催化剂条件下5-[(3-吲哚基)-芳甲基]-2,2-二甲基- 1,3-二氧六环-4,6-二酮的合成

在无溶剂和催化剂条件下,由芳香醛、吲哚、丙二酸亚异丙酯的三组分缩合反应,制备了5-[(3-吲哚基)-芳甲基]-2,2-二甲基-1,3-二氧六环-4,6-二酮,产率为70%～85%,产物结构经1H NMR,IR确证.     

1,2-二甲基-3-吲哚甲叉(异丙叉)丁二酸酐(1)和1,2-二甲基-3-吲哚乙叉(异丙叉)丁二酸酐(2)的晶体结构

1.2-二甲基-3-吲哚甲叉(异丙叉)丁二酸酐(1)(C_(18)H_(17)NO_3)与1.2-二甲基-3-吲哚乙叉(异丙叉)丁二酸酐(2)(C_(19)H_(19)NO_3)同属于吲哚俘精酸类化合物,它们的分子结构非常类似,只是(1)中为吲哚甲叉,(2)中为吲哚乙叉.但它们的光色性却差别很大.化合物(1)无光致变色性,化合物(2)则表现为良好的光致变色性.其原因在于结构的不同。     

无溶剂条件下合成顺/反3-芳基亚甲基-2,3-二氢-吲哚-2-酮类化合物

无溶剂条件下, 芳香醛与2-吲哚酮在碱性条件下通过研磨, 方便有效地合成了一系列3-芳基亚甲基-2,3-二氢- 吲哚-2-酮类化合物, 该反应条件温和, 时间短, 产率高, 对环境友好. 产物的结构得到¹H NMR, IR, HRMS的表征, 其中(Z)-3e和(Z)-3j的结构得到了X单晶衍射的进一步确证.     

5-[5-(3-吡啶)-2H-四唑亚甲基]-2-芳酰氨基-1,3,4-噻二唑的合成

本文首先用5-(3-吡啶)-2H-四唑乙酰基酰肼与芳酰基异硫氰酸盐反应制备成化合物1-[5-(3-吡啶)-2H-四唑乙酰基]-4-芳酰氨基硫脲化合物1a～j, 然后用冰醋酸回流处理1a～j得到一系列化合物5-[5-(3-吡啶)-2H-四唑亚甲基]-2-芳酰氨基-1,3,4-噻二唑2a～j . 化合物1a～b在强碱介质中首先发生降解, 然后进行环化反应 .     

Umsetzung von 3-(Dimethylamino)-2H-azirinen mit 1,3-Oxazolidin-2-thion zu 3-(2-Hydroxyethyl)-2-thiohydantoinen

Reaction of 3-(Dimethylamino)-2H-azirines with 1,3-Oxazolidine-2-thione to 3-(2-Hydroxyethyl)-2- thiohydantoins The reaction of 3-(dimethylamino)-2H-azirines 1 and 1,3-oxazolidine-2-thione ( 6 ), in MeCN at room temperature, yields, after hydrolytic workup, 3-(2-hydroxyethyl)-2-thiohydantoins 7 (Scheme 2). In the case of the spirocyclic 1c , crystallization of the crude reaction mixture leads to spiro [cyclopentane-1, 7′(7′aH)-imidazo [4, 3-b] oxazole] -5′-thione 8c . The mechanism is discussed.     

Synthesis of 3- and 5-amino-5-(3)-(pyrrol-2-yl)isoxazoles

5-Amino-3-(pyrrol-2-yl)isoxazoles were selectively prepared by the reaction of 2-(2,2-dicyano-1-ethylthioethenyl)pyrroles with hydroxylamine in methanol. Under analogous conditions, 2-(2-carbamoyl-2-cyano-1-ethylthioethenyl) pyrroles with hydroxylamine gave 5-aminoisoxazoles and their structural isomers, 3-aminoisoxazoles (3-5% yield). The latter were selectively prepared by reacting 2-(2-carbamoyl-2-cyano-1-ethylthioethenyl)pyrroles with hydroxylamine in the presence of aqueous NaOH and from the products of intramolecular cyclization of 2-(2-carbamoyl-2-cyano-1-ethylthioethenyl)pyrroles, 1-ethylthio-3-iminopyrrolizines and hydroxylamine.     

Synthesis and E/Z configuration determination of novel derivatives of 3-aryl-2-(benzothiazol-2'-ylthio) acrylonitrile, 3-(benzothiazol-2'-ylthio)-4-(furan-2'-yl)-3-buten-2-one and 2-(1-(furan-2'-yl)-3'-oxobut-1'-en-2-ylthio)-3-phenylquinazolin-4(3H)-one

Knoevenagel condensation of 2-(benzothiazol-2-ylthio) acetonitrile (2) with either furan-2-carbaldehyde or thiophene-2-carbaldehydes leads to E-isomers 4a-b exclusively, while the condensation of the compound 2 with benzaldehyde or para-substituted benzaldehydes with an electron-donating group afforded E/Z mixtures 4c-e with preferentially formation of the E-isomer. Condensation of furan-2-carbaldehyde (3a) with either 1-(benzothiazol-2'-ylthio) propan-2-one (5) or 2-(2'-oxo propylthio)-3-phenyl-quinazolin-4(3H)-one (9) leads exclusively to the Z-isomers of 6 and 10, respectively. The structures of the newly synthesized compounds were elucidated by elemental analyses, 1H-NMR and 13C-NMR spectra, COSY, HSQC, HMBC, NOE, MS and X-ray crystallographic investigations.     

Synthesis of 2-(2′,3′-dihydroxypropyl)-5-amino-2H-1,2,4-thiadiazol-3-one and 3-(2′,3′-dihydroxypropyl)-5-amino-3H-1,3,4-thiadiazol-2-one

The synthesis of two new acyclic nucleoside analogs, 2-(2′,3′-dihydroxypropyl)-5-amino-2H-1,2,4-thiadiazol-3-one (1) and 3-(2′,3′-dihydroxypropyl)-5-amino-3H-1,3,4-thiadiazol-2-one (2), is reported. The first compound, 1, was obtained by reaction of 3-chloro-1,2-propanediol with the sodium salt of 5-amino-2H-1,2,4-thiadiazol-3-one (3) in anhydrous dimethylformamide. Similarly, 5-amino-3H-1,3,4-thiadiazol-2-one (4) reacted with 3-chloro-1,2-propanediol to give 2. The thiadiazole 4 was prepared by condensation-cyclization of hydrazothiodicarbonamide (9).     

3-Alkyl-2-[3(4)-pyridyl]-5-(2-vinyloxyethoxymethyl)-oxazolidines

1-Alkylamino-3-(2-vinyloxyethoxy)-2-propanols react with 3-and 4-pyridinecarbaldehydes to give equimolar mixtures of cis- and trans-3-alkyl-5-(2-vinyloxyethoxymethyl)-2-[3(4)-pyridyl]oxazolidines.__________Translated from Zhurnal Organicheskoi Khimii, Vol. 41, No. 1, 2005, pp. 104–108.Original Russian Text Copyright © 2005 by Kukharev, Stankevich, Lobanova, Klimenko, Kukhareva.     

Synthesis of 2-(2-Naphthyl)quinolines from Z-3-(2-Naphthyl)-3-chloro-2-propenal

By reaction of Z-3-(2-naphthyl)-3-chloro-2-propenal and aromatic amines 1-(2-naphthyl)-3-iminoaryl-1-propenylarylamines were prepared which at heating in the glacial acetic acid afforded the corresponding 2-(2-naphthyl)quinolines.     

Asymmetric synthesis of (1R,2S,3R)-3-methylcispentacin and (1S,2S,3R)-3-methyltranspentacin by kinetic resolution of tert-butyl (+/-)-3-methylcyclopentene-1-carboxylate

Conjugate addition of lithium dibenzylamide to tert-butyl (+/-)-3-methylcyclopentene-1-carboxylate occurs with high levels of stereocontrol, with preferential addition of lithium dibenzylamide to the face of the cyclic alpha,beta-unsaturated acceptor anti- to the 3-methyl substituent. High levels of enantiorecognition are observed between tert-butyl (+/-)-3-methylcyclopentene-1-carboxylate and an excess of lithium (+/-)-N-benzyl-N-alpha-methylbenzylamide (10 eq.) (E > 140) in their mutual kinetic resolution, while the kinetic resolution of tert-butyl (+/-)-3-methylcyclopentene-1-carboxylate with lithium (S)-N-benzyl-N-alpha-methylbenzylamide proceeds to give, at 51% conversion, tert-butyl (1R,2S,3R,alphaS)-3-methyl-2-N-benzyl-N-alpha-methylbenzylaminocyclopentane-1-carboxylate consistent with E > 130, and in 39% yield and 99 +/- 0.5% de after purification. Subsequent deprotection by hydrogenolysis and ester hydrolysis gives (1R,2S,3R)-3-methylcispentacin in > 98% de and 98 +/- 1% ee. Selective epimerisation of tert-butyl (1R,2S,3R,alphaS)-3-methyl-2-N-benzyl-N-alpha-methylbenzylaminocyclopentane-1-carboxylate by treatment with KO'Bu in 'BuOH gives tert-butyl (1S,2S,3R,alphaS)-3-methyl-2-N-benzyl-N-alpha-methylbenzylaminocyclopentane-1-carboxylate in quantitative yield and in > 98% de, with subsequent deprotection by hydrogenolysis and ester hydrolysis giving (1S,2S,3R)-3-methyltranspentacin hydrochloride in > 98% de and 97 +/- 1% ee.     

Pyridine-substituted hydroxythiophenes. IV. Preparation of 3- and 4-(2-, 3- and 4-pyridyl)-2-hydroxythiophenes

3-(2-, 3- and 4-Pyridyl)-2-methoxythiophenes have been prepared in good yields through the Pd(0)-cat-alyzed coupling of the three isomeric bromopyridines with 3-trimethylstannyl-2-methoxythiophene. This compound was prepared through halogen-metal exchange of 3-bromo-2-methoxythiophene followed by stannylation. 3-Bromo-2-methoxythiophene was prepared by dibromination and α-debromination of 2-methoxythiophen. Most attempts to demethylate 2-methoxy-3-pyridylthiophenes using a large variety of reagents failed, probably due to the instability and high reactivity of the desired 3-pyridyl-2-hydroxythiophene systems. Only 2-methoxy-3-(3-pyridyl)thiophene reacted with boron tribromide to give 3-(3-pyridyl)-3-thiolene-2-one, which only was stable in ether solution at ?20°. The attempted demethylation of 2-methoxy-3-(2-pyridyl)thiophene with trimethylsilane chloride/sodium iodide in refluxing acetonitrile led to a dimer. Demethylation of the 2-methoxy-3-pyridylthiophenes with dibenzyl diselenide and sodium borohydride gave 3-pyridylthiophan-2-ones. A number of other routes to prepare 3-pyridyl-2-hydroxythiophenes were also explored, but none of them gave the desired compounds. On the other hand, the 4-(2-, 3-, and 4-pyridyl)-2-hydroxythiophene systems could easily be prepared by hydrogen peroxide oxidation of the corresponding 4-pyridyl-2-thiopheneboronic esters, which were obtained from 2-bromo-4-pyridylthiophenes by halogen-metal exchange followed by reaction with ethyl borate. The 2-bromo-4-pyridylthiophenes were prepared by dibromination of the known 3-pyridylthiophenes to the 2,5-dibromo derivatives, and removal of the 2-bromine by halogen-metal exchange at ?100°, followed by hydrolysis. The ¹H nmr and ir spectroscopic investigations show that these quite stable 2-hydroxythiophene systems exist exclusively in the 4-pyridyl-3-thiolen-2-one forms.     

5-[5-(3-吡啶)-2H-四唑亚甲基]-2-芳酰氨基-1,3,4-噻二唑的合成

正如前文报道,l,3,4—噻二唑类杂环之所以有除草,植物生长调节,驱虫以及消炎等多种生物活性,无疑起因于噻唑母核。尽管母核上取代基不起主导作用,但它作为辅助基,在改善分子溶解性以及药效方面所产生的影响是不能忽略的。因而深入研究各种生物活性基团导入噻二唑环母核以制得多结构单元聚集于同一分子中的噻二唑新衍生物,对于开发多功能新药具有一定的理论意义和实际价值。